Skip to Main Content

Author Details

Peter K Linden
Allegheny General Hospital
1991
62
37
PMIDPaper TitleJournal TitlePublished Year
28807042Incidence, prevalence, and management of MRSA bacteremia across patient populations-a review of recent developments in MRSA management and treatment.Crit Care2017
19933807Voriconazole pharmacokinetics in liver transplant recipients.Antimicrob Agents Chemother2010
19268801History of solid organ transplantation and organ donation.Crit Care Clin2009
19665082Approach to the immunocompromised host with infection in the intensive care unit.Infect Dis Clin North Am2009
18025111Acquisition of rectal colonization by vancomycin-resistant Enterococcus among intensive care unit patients treated with piperacillin-tazobactam versus those receiving cefepime-containing antibiotic regimens.Antimicrob Agents Chemother2008
18778223Health care-associated infection (HAI): a critical appraisal of the emerging threat-proceedings of the HAI Summit.Clin Infect Dis2008
19053904Vancomycin resistance: are there better glycopeptides coming?Expert Rev Anti Infect Ther2008
18581484Noninvasive monitoring of cerebral perfusion pressure in patients with acute liver failure using transcranial doppler ultrasonography.Liver Transpl2008
18379262Guidelines for evaluation of new fever in critically ill adult patients: 2008 update from the American College of Critical Care Medicine and the Infectious Diseases Society of America.Crit Care Med2008
17313467Cryptococcosis in liver and kidney transplant recipients receiving anti-thymocyte globulin or alemtuzumab.Transpl Infect Dis2007
18095227Optimizing therapy for vancomycin-resistant enterococci (VRE).Semin Respir Crit Care Med2007
17521455Steroids in early ARDS?Crit Care2007
17703923Pseudomonas aeruginosa infections in the Intensive Care Unit: can the adequacy of empirical beta-lactam antibiotic therapy be improved?Int J Antimicrob Agents2007
17696578Safety profile of meropenem: an updated review of over 6,000 patients treated with meropenem.Drug Saf2007
16925570Zygomycosis in solid organ transplant recipients in a tertiary transplant center and review of the literature.Am J Transplant2006
16779742Epidemiological profile of linezolid-resistant coagulase-negative staphylococci.Clin Infect Dis2006
16894521Parenteral and inhaled colistin for treatment of ventilator-associated pneumonia.Clin Infect Dis2006
15947332Effect of granulocyte-monocyte colony-stimulating factor therapy on leukocyte function and clearance of serious infection in nonneutropenic patients.Chest2005
16207962SHV-type extended-spectrum beta-lactamase production is associated with Reduced cefepime susceptibility in Enterobacter cloacae.J Clin Microbiol2005
15494908The importance of bactericidal drugs: future directions in infectious disease.Clin Infect Dis2004
15257625Newer treatment options for skin and soft tissue infections.Drugs2004
12491201Trends in risk profiles for and mortality associated with invasive aspergillosis among liver transplant recipients.Clin Infect Dis2003
13678566Can Enterococcal Infections Initiate Sepsis Syndrome?Curr Infect Dis Rep2003
14605534Reassessing the value of short-term mortality in sepsis: comparing conventional approaches to modeling.Crit Care Med2003
14596663Amphotericin B lipid complex for the treatment of invasive fungal infections.Expert Opin Pharmacother2003
14614688Use of parenteral colistin for the treatment of serious infection due to antimicrobial-resistant Pseudomonas aeruginosa.Clin Infect Dis2003
12830404Invasive aspergillosis in liver transplant recipients: outcome comparison of therapy with amphotericin B lipid complex and a historical cohort treated with conventional amphotericin B.Clin Infect Dis2003
12856215Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi.Clin Infect Dis2003
11827558Treatment options for vancomycin-resistant enterococcal infections.Drugs2002
12173131Association between the presence of enterococcal virulence factors gelatinase, hemolysin, and enterococcal surface protein and mortality among patients with bacteremia due to Enterococcus faecalis.Clin Infect Dis2002
11399716Acute respiratory failure associated with pulmonary cryptococcosis in non-aids patients.Chest2001
11588692Effective suppression of vancomycin-resistant Enterococcus species in asymptomatic gastrointestinal carriers by a novel glycolipodepsipeptide, ramoplanin.Clin Infect Dis2001
11668430Treatment of vancomycin-resistant Enterococcus faecium infections with quinupristin/dalfopristin.Clin Infect Dis2001
11578151Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia. a prospective multicenter study.Ann Intern Med2001
11401179Hyperbilirubinemia during quinupristin-dalfopristin therapy in liver transplant recipients: correlation with available liver biopsy results.Pharmacotherapy2001
10945204Efficacy and safety of amphotericin B lipid complex injection (ABLC) in solid-organ transplant recipients with invasive fungal infections.Clin Transplant2000
10555932Retrospective analysis of the dosage of amphotericin B lipid complex for the treatment of invasive fungal infections.Pharmacotherapy1999
10473233The efficacy and safety of quinupristin/dalfopristin for the treatment of infections caused by vancomycin-resistant Enterococcus faecium. Synercid Emergency-Use Study Group.J Antimicrob Chemother1999
11095827Quinupristin-Dalfopristin.Curr Infect Dis Rep1999
10091034Vancomycin-resistant enterococci: the clinical effect of a common nosocomial pathogen.Diagn Microbiol Infect Dis1999
9684650The specter of glycopeptide resistance: current trends and future considerations. Introduction.Am J Med1998
9468180Practice parameters for evaluating new fever in critically ill adult patients. Task Force of the American College of Critical Care Medicine of the Society of Critical Care Medicine in collaboration with the Infectious Disease Society of America.Crit Care Med1998
9642523Disseminated histoplasmosis in a patient after orthotopic liver transplantation.Clin Transplant1998
9597223Practice guidelines for evaluating new fever in critically ill adult patients. Task Force of the Society of Critical Care Medicine and the Infectious Diseases Society of America.Clin Infect Dis1998
9684655Clinical implications of nosocomial gram-positive bacteremia and superimposed antimicrobial resistance.Am J Med1998
9511079Effect of quinupristin/dalfopristin on the outcome of vancomycin-resistant Enterococcus faecium bacteraemia: comparison with a control cohort.J Antimicrob Chemother1997
9201052Utilization and diagnostic yield of blood cultures in a surgical intensive care unit.Crit Care Med1997
9395355Posttransplant lymphoproliferative disease in primary Epstein-Barr virus infection after liver transplantation: the role of cytomegalovirus disease.J Infect Dis1997
8554421Factors associated with the development of candidemia and candidemia-related death among liver transplant recipients.Ann Surg1996
8729206Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E. faecium.Clin Infect Dis1996
  • 1 - 50 of 62

Recommended Authors

Matthew W McCarthy
Weill Cornell Medical College, New York-Presbyterian Hospital
Career Start Year 2014
Number of shared co-authors 0
Monica V Mahoney
Department of Pharmacy, Beth Israel Deaconess Medical Center
Career Start Year 2013
Number of shared co-authors 0
Heather A Personett
Department of Pharmacy, Mayo Clinic
Career Start Year 2012
Number of shared co-authors 0
Me-Linh Luong
Centre Hospitalier de l'Universite de Montreal
Career Start Year 2008
Number of shared co-authors 2
Enrico Maria Trecarichi
University "Magna Graecia"
Career Start Year 2006
Number of shared co-authors 0
Johanna Osorio
Hospital Universitario Hernando Moncaleano Perdomo
Career Start Year 2006
Number of shared co-authors 0
Anurag N Malani
Trinity Health St Joseph Mercy Hospital
Career Start Year 2005
Number of shared co-authors 1
Parham Sendi
Institute for Infectious Diseases, University of Bern
Career Start Year 2004
Number of shared co-authors 0
Paschalis Vergidis
Mayo Clinic
Career Start Year 2004
Number of shared co-authors 1
Arun Chopra
The Center for Pediatric Pharmacotherapy LLC
Career Start Year 2003
Number of shared co-authors 0
Steven I Aronin
Waterbury Hospital
Career Start Year 1998
Number of shared co-authors 0
George M Lyon
Emory University School of Medicine
Career Start Year 1997
Number of shared co-authors 3
Miguel S??nchez Garc??a
Hospital Clinico San Carlos
Career Start Year 1996
Number of shared co-authors 0
Priya Sampathkumar
Mayo Clinic
Career Start Year 1994
Number of shared co-authors 1
Ebbing Lautenbach
Perelman School of Medicine, University of Pennsylvania
Career Start Year 1994
Number of shared co-authors 1
Juan Pablo Horcajada
Hospital del Mar-IMIM, Universitat Pompeu Fabra, Instituto de Salud Carlos III
Career Start Year 1993
Number of shared co-authors 0
Shmuel Shoham
Johns Hopkins School of Medicine, Johns Hopkins University
Career Start Year 1993
Number of shared co-authors 3
Jos?? Barber??n
Hospital Universitario HM Monteprincipe, HM Hospitales
Career Start Year 1991
Number of shared co-authors 0
Paloma Gij??n
Instituto de Investigacion Sanitaria Gregorio Maranon (IiSGM)
Career Start Year 1991
Number of shared co-authors 0
Steven Q Simpson
University of Kansas Medical Center
Career Start Year 1989
Number of shared co-authors 3
Jes??s Fort??n
Hospital Universitario Ramon y Cajal
Career Start Year 1988
Number of shared co-authors 2
A M Joffe
University of Washington
Career Start Year 1988
Number of shared co-authors 0
Pierre-Fran??ois Laterre
Centre Hospitalier Regional Mons-Hainaut
Career Start Year 1986
Number of shared co-authors 5
John C Marshall
St. Michael's Hospital
Career Start Year 1986
Number of shared co-authors 5
Arthur P Wheeler
Vanderbilt University
Career Start Year 1984
Number of shared co-authors 3
Coleman Rotstein
University of Toronto, and University Health Network, Toronto General Hospital
Career Start Year 1982
Number of shared co-authors 1
Bernard M Kubak
David Geffen School of Medicine at university of california los angeles
Career Start Year 1981
Number of shared co-authors 1
Steven M Opal
Infectious Disease Division at Brown University Warren Alpert Medical School
Career Start Year 1979
Number of shared co-authors 4
Bruce S Ribner
Emory University School of Medicine
Career Start Year 1975
Number of shared co-authors 1
Howard Levy
Howard Levy Consulting LLC
Career Start Year 1966
Number of shared co-authors 3

Collaborators

David J Kramer
University of Wisconsin School of Medicine and Public Health in Madison
Co-authored papers 9
Shahid Husain
University Health Network
Co-authored papers 4
Thomas P Bleck
Northwestern University Feinberg School of Medicine
Co-authored papers 3
Michael R Pinsky
University of Pittsburgh
Co-authored papers 2
Derek C Angus
University of Pittsburgh Medical Center
Co-authored papers 2
Fernanda P Silveira
Federal University of Rio de Janeiro
Co-authored papers 2
G Clermont
University of Pittsburgh
Co-authored papers 1
Walter T Linde-Zwirble
The CRISMA Laboratory (Clinical Research, University of Pittsburgh
Co-authored papers 1
Kyle Soltys
Co-authored papers 1
Melissa Saul
University of Pittsburgh Medical Center
Co-authored papers 1
Kenneth G Kalassian
Stanford University Medical Center
Co-authored papers 1
Andre C Kalil
University of Nebraska School of Medicine
Co-authored papers 1
Vance G Fowler
Duke University School of Medicine
Co-authored papers 1
Nagarajan Ramakrishnan
Apollo Hospitals Enterprise Ltd
Co-authored papers 1
Richard G Wunderink
Northwestern University Feinberg School of Medicine
Co-authored papers 1
Marjorie Romkes
Co-authored papers 1
Lena M Napolitano
University of Michigan ann arbor
Co-authored papers 1
Raghavan Murugan
University of Pittsburgh School of Medicine
Co-authored papers 1
Carol A Kauffman
Co-authored papers 1
Eric B Milbrandt
The CRISMA Center (Clinical Research, University of Pittsburgh
Co-authored papers 1
Release 1.2